Compugen Ltd SEC filings CGEN
Compugen Ltd has 607 filings in SEC EDGAR's recent list, going back to Feb 13, 2001. Its latest annual report, Form 20-F, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Sep 10, 2026 |
| UPLOAD | Letter from the SEC | Aug 4, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Jun 30, 2026 |
| CORRESP | Letter to the SEC | Jul 28, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2026 | — |
| EFFECT | Filing | Jun 8, 2026 | — |
| CORRESP | Letter to the SEC | Jun 4, 2026 | — |
| UPLOAD | Letter from the SEC | May 21, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | May 18, 2026 | — |
| 6-K | Current report (foreign issuer) | May 18, 2026 | May 18, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 2, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Mar 2, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 6-K | Current report (foreign issuer) | Dec 17, 2025 | Dec 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 6-K | Current report (foreign issuer) | Oct 14, 2025 | Oct 14, 2025 |
| 6-K | Current report (foreign issuer) | Sep 17, 2025 | Sep 17, 2025 |
| 6-K | Current report (foreign issuer) | Aug 6, 2025 | Aug 6, 2025 |
| 6-K | Current report (foreign issuer) | Aug 6, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 21, 2025 | Jul 21, 2025 |
| 6-K | Current report (foreign issuer) | May 19, 2025 | May 19, 2025 |
| 6-K | Current report (foreign issuer) | May 13, 2025 | May 13, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 4, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 4, 2025 | Mar 4, 2025 |
| 6-K | Current report (foreign issuer) | Jan 8, 2025 | Jan 8, 2025 |
| 6-K | Current report (foreign issuer) | Nov 27, 2024 | Nov 27, 2024 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 12, 2024 |
| 6-K | Current report (foreign issuer) | Nov 5, 2024 | Nov 5, 2024 |
| 6-K | Current report (foreign issuer) | Sep 13, 2024 | Sep 13, 2024 |
| 6-K | Current report (foreign issuer) | Aug 6, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 5, 2024 | Aug 5, 2024 |
| 6-K | Current report (foreign issuer) | Jul 29, 2024 | Jul 29, 2024 |
| 6-K | Current report (foreign issuer) | May 30, 2024 | May 30, 2024 |
| 6-K | Current report (foreign issuer) | May 20, 2024 | May 20, 2024 |
| 6-K | Current report (foreign issuer) | May 15, 2024 | May 15, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 5, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 5, 2024 | Mar 5, 2024 |
| 6-K | Current report (foreign issuer) | Feb 15, 2024 | Feb 15, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2024 | Jan 8, 2024 |
| 6-K | Current report (foreign issuer) | Dec 19, 2023 | Dec 19, 2023 |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Nov 7, 2023 |
| 6-K | Current report (foreign issuer) | Nov 6, 2023 | Nov 6, 2023 |
| 6-K | Current report (foreign issuer) | Nov 3, 2023 | Nov 3, 2023 |
| 6-K | Current report (foreign issuer) | Sep 21, 2023 | Sep 21, 2023 |
| UPLOAD | Letter from the SEC | Aug 24, 2023 | — |
| CORRESP | Letter to the SEC | Aug 23, 2023 | — |
| 20-F/A | Amended annual report (foreign issuer) | Aug 23, 2023 | Dec 31, 2022 |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Aug 7, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 23, 2023 | — |
| F-3/A | Filing | Jun 23, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 22, 2023 | Jun 22, 2023 |
| 6-K | Current report (foreign issuer) | Jun 13, 2023 | Jun 13, 2023 |
| 6-K | Current report (foreign issuer) | Jun 5, 2023 | Jun 5, 2023 |
| 6-K | Current report (foreign issuer) | May 15, 2023 | May 15, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| CORRESP | Letter to the SEC | Apr 14, 2023 | — |
| F-3/A | Filing | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 30, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| 6-K | Current report (foreign issuer) | Mar 6, 2023 | Mar 6, 2023 |
| 20-F | Annual report (foreign issuer) | Feb 28, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Feb 27, 2023 | Feb 27, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Jan 31, 2023 | Jan 31, 2023 |
| 424B5 | Prospectus supplement | Jan 31, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 6, 2022 | Dec 6, 2022 |
| 6-K | Current report (foreign issuer) | Dec 2, 2022 | Dec 2, 2022 |
| 6-K | Current report (foreign issuer) | Dec 1, 2022 | Dec 1, 2022 |
| 6-K | Current report (foreign issuer) | Nov 16, 2022 | Nov 16, 2022 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Nov 14, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Nov 2, 2022 |
| 6-K | Current report (foreign issuer) | Sep 22, 2022 | Sep 22, 2022 |
| 6-K | Current report (foreign issuer) | Sep 15, 2022 | Sep 15, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Sep 12, 2022 |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Aug 4, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Aug 4, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Aug 4, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | May 16, 2022 | May 16, 2022 |
| 6-K | Current report (foreign issuer) | May 10, 2022 | May 10, 2022 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 28, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 28, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Feb 24, 2022 | Feb 24, 2022 |
| D | Filing | Nov 22, 2021 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2021 | Nov 12, 2021 |
| 6-K | Current report (foreign issuer) | Nov 12, 2021 | Nov 12, 2021 |
| 6-K | Current report (foreign issuer) | Sep 2, 2021 | Sep 2, 2021 |
| 6-K | Current report (foreign issuer) | Jul 29, 2021 | Jul 29, 2021 |
| 6-K | Current report (foreign issuer) | Jul 28, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Jun 8, 2021 | Jun 8, 2021 |
| 6-K | Current report (foreign issuer) | May 13, 2021 | May 13, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 25, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Feb 25, 2021 | Feb 25, 2021 |
| 6-K | Current report (foreign issuer) | Feb 22, 2021 | Feb 22, 2021 |
| 6-K | Current report (foreign issuer) | Dec 23, 2020 | Dec 23, 2020 |
| 6-K | Current report (foreign issuer) | Dec 10, 2020 | Dec 10, 2020 |
| S-8 | Employee stock plan registration | Dec 10, 2020 | — |
| 6-K | Current report (foreign issuer) | Nov 5, 2020 | Nov 5, 2020 |
| 6-K | Current report (foreign issuer) | Sep 17, 2020 | Sep 17, 2020 |
| 6-K | Current report (foreign issuer) | Sep 8, 2020 | Sep 8, 2020 |
| EFFECT | Filing | Aug 7, 2020 | — |
| CORRESP | Letter to the SEC | Aug 5, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2020 | — |
| 6-K | Current report (foreign issuer) | Aug 5, 2020 | Aug 5, 2020 |
| F-3 | Shelf registration (foreign issuer) | Jul 30, 2020 | — |
| S-8 | Employee stock plan registration | Jul 30, 2020 | — |
| 6-K | Current report (foreign issuer) | Jul 30, 2020 | Jun 30, 2020 |
| 6-K | Current report (foreign issuer) | Jun 1, 2020 | Jun 1, 2020 |
| 6-K | Current report (foreign issuer) | May 27, 2020 | May 27, 2020 |
| 6-K | Current report (foreign issuer) | May 6, 2020 | May 6, 2020 |
| 6-K | Current report (foreign issuer) | Apr 27, 2020 | Apr 27, 2020 |
| 6-K | Current report (foreign issuer) | Apr 15, 2020 | Apr 15, 2020 |
| 6-K | Current report (foreign issuer) | Apr 6, 2020 | Apr 6, 2020 |
| 6-K | Current report (foreign issuer) | Mar 17, 2020 | Mar 17, 2020 |
| 6-K | Current report (foreign issuer) | Mar 13, 2020 | Mar 13, 2020 |
| 424B5 | Prospectus supplement | Mar 12, 2020 | — |
| 6-K | Current report (foreign issuer) | Mar 12, 2020 | Mar 12, 2020 |
| 6-K | Current report (foreign issuer) | Mar 11, 2020 | Mar 11, 2020 |
| 424B5 | Prospectus supplement | Mar 11, 2020 | — |
| 6-K | Current report (foreign issuer) | Mar 9, 2020 | Mar 9, 2020 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 27, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Feb 24, 2020 | Dec 31, 2019 |
| 6-K | Current report (foreign issuer) | Feb 20, 2020 | Feb 20, 2020 |
| 6-K | Current report (foreign issuer) | Feb 20, 2020 | Feb 20, 2020 |
| 6-K | Current report (foreign issuer) | Jan 9, 2020 | Jan 9, 2020 |
| 6-K | Current report (foreign issuer) | Nov 12, 2019 | Nov 12, 2019 |
| 6-K | Current report (foreign issuer) | Nov 5, 2019 | Nov 5, 2019 |
| 6-K | Current report (foreign issuer) | Nov 4, 2019 | Nov 4, 2019 |
| 6-K | Current report (foreign issuer) | Sep 19, 2019 | Sep 19, 2019 |
| EFFECT | Filing | Aug 12, 2019 | — |
| CORRESP | Letter to the SEC | Aug 8, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 5, 2019 | — |
| 6-K | Current report (foreign issuer) | Aug 5, 2019 | Jun 30, 2019 |
| 6-K | Current report (foreign issuer) | Jul 2, 2019 | Jul 2, 2019 |
| CT ORDER | Filing | May 30, 2019 | — |
| 6-K | Current report (foreign issuer) | May 20, 2019 | May 20, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2019 | Dec 31, 2018 |
| 6-K | Current report (foreign issuer) | Feb 26, 2019 | Feb 26, 2019 |
| CT ORDER | Filing | Dec 4, 2018 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2018 | Nov 7, 2018 |
| D | Filing | Oct 16, 2018 | — |
| 6-K | Current report (foreign issuer) | Oct 11, 2018 | Oct 11, 2018 |
| 6-K | Current report (foreign issuer) | Sep 20, 2018 | Sep 20, 2018 |
| 6-K | Current report (foreign issuer) | Sep 7, 2018 | Sep 7, 2018 |
| 6-K | Current report (foreign issuer) | Sep 5, 2018 | Sep 5, 2018 |
| CT ORDER | Filing | Sep 4, 2018 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2018 | Aug 7, 2018 |
| 6-K | Current report (foreign issuer) | Aug 1, 2018 | Aug 1, 2018 |
| 6-K | Current report (foreign issuer) | Jul 2, 2018 | Jul 2, 2018 |
| 6-K | Current report (foreign issuer) | Jun 28, 2018 | Jun 28, 2018 |
| 6-K | Current report (foreign issuer) | Jun 19, 2018 | Jun 19, 2018 |
| 424B5 | Prospectus supplement | Jun 18, 2018 | — |
| 6-K | Current report (foreign issuer) | Jun 15, 2018 | Jun 15, 2018 |
| 6-K | Current report (foreign issuer) | Jun 11, 2018 | Jun 11, 2018 |
| 6-K | Current report (foreign issuer) | Jun 4, 2018 | Jun 4, 2018 |
| 424B5 | Prospectus supplement | May 25, 2018 | — |
| 6-K | Current report (foreign issuer) | May 25, 2018 | May 25, 2018 |
| CT ORDER | Filing | May 18, 2018 | — |
| 6-K | Current report (foreign issuer) | May 9, 2018 | May 9, 2018 |
| 6-K | Current report (foreign issuer) | Apr 27, 2018 | Apr 27, 2018 |
| 6-K | Current report (foreign issuer) | Apr 2, 2018 | Apr 2, 2018 |
| S-8 | Employee stock plan registration | Mar 27, 2018 | — |
| 20-F | Annual report (foreign issuer) | Mar 27, 2018 | Dec 31, 2017 |
| 6-K | Current report (foreign issuer) | Mar 14, 2018 | Mar 14, 2018 |
| 6-K | Current report (foreign issuer) | Feb 21, 2018 | Feb 21, 2018 |
| 6-K | Current report (foreign issuer) | Feb 6, 2018 | Feb 6, 2018 |
| 6-K | Current report (foreign issuer) | Jan 31, 2018 | Jan 31, 2018 |
| 6-K | Current report (foreign issuer) | Dec 18, 2017 | Dec 18, 2017 |
| 6-K | Current report (foreign issuer) | Nov 7, 2017 | Nov 7, 2017 |
| 6-K | Current report (foreign issuer) | Nov 6, 2017 | Nov 6, 2017 |
| 6-K | Current report (foreign issuer) | Oct 19, 2017 | Oct 19, 2017 |
| 6-K | Current report (foreign issuer) | Sep 6, 2017 | Sep 6, 2017 |
| CT ORDER | Filing | Aug 14, 2017 | — |
| 6-K | Current report (foreign issuer) | Aug 2, 2017 | Aug 2, 2017 |
| 6-K | Current report (foreign issuer) | Jul 26, 2017 | Jul 26, 2017 |
| 6-K | Current report (foreign issuer) | Jul 14, 2017 | Jul 14, 2017 |
| 6-K | Current report (foreign issuer) | Jul 13, 2017 | Jul 13, 2017 |
| 6-K | Current report (foreign issuer) | May 31, 2017 | May 31, 2017 |
| 6-K | Current report (foreign issuer) | May 30, 2017 | May 30, 2017 |
| 6-K | Current report (foreign issuer) | May 25, 2017 | May 25, 2017 |
| 6-K | Current report (foreign issuer) | May 9, 2017 | May 9, 2017 |
| 6-K | Current report (foreign issuer) | Mar 28, 2017 | Mar 28, 2017 |
| 20-F | Annual report (foreign issuer) | Feb 16, 2017 | Dec 31, 2016 |
| 6-K | Current report (foreign issuer) | Feb 15, 2017 | Feb 15, 2017 |
| 6-K | Current report (foreign issuer) | Dec 8, 2016 | Dec 8, 2016 |
| 6-K | Current report (foreign issuer) | Dec 7, 2016 | Dec 7, 2016 |
| 6-K | Current report (foreign issuer) | Nov 14, 2016 | Nov 14, 2016 |
| 6-K | Current report (foreign issuer) | Nov 7, 2016 | Nov 7, 2016 |
| 424B2 | Prospectus | Oct 14, 2016 | — |
| EFFECT | Filing | Oct 11, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Holon, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1119774
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.